REFERENCES

• HuberG.GrossG.SchüttlerR.LinzM.Longitudinal studies of schizophrenic patients.Schizophr Bull.198065926057444391
   PubMed Web of Science ®Google Scholar
• CiompiL.Catamnestic long-term study on the course of life and aging of schizophrenics.Schizophr Bull.198066066187444392
   PubMed Web of Science ®Google Scholar
• BreierA.SchreiberJL.DyerJ.PickarD.National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome.Arch Gen Psychiatry.1991482392461671741
   PubMed Web of Science ®Google Scholar
• RamR.BrometEJ.EatonWW.PatoC.SchwartzJE.The natural course of schizophrenia: a review of first-admission studies.Schizophr Bull.199281852071621068
   PubMedGoogle Scholar
• HegartyJD.BaldessariniRJ.TohenM.WaternauxC.OepenG.One hundred years of schizophrenia: a meta-analysis of the outcome literature.Am J Psychiatry.1994151140914168092334
   PubMed Web of Science ®Google Scholar
• AltamuraAC.BoboWV.MeltzerHY.Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment.Int Clin Psychopharmacol.20072224926717690594
   PubMed Web of Science ®Google Scholar
• MöllerHJ.JägerM.RiedelM.ObermeierM.StraussA.BottlenderR.The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity.Eur Arch Psychiatry Clin Neurosci.201026036738420495979
   PubMed Web of Science ®Google Scholar
• ZipurskyRB.MenezesNM.StreinerDL.Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review.Schizophr Res.201415240841423972821
   PubMed Web of Science ®Google Scholar
• SchennachR.RiedelM.MusilR.MollerHJ.Treatment response in firstepisode schizophrenia.Clin Psychopharmacol Neurosci.201210788723430971
   PubMedGoogle Scholar
• LangFU.KöstersM.LangS.BeckerT.JägerM.Psychopathological long-term outcome of schizophrenia - a review.Acta Psychiatr Scand.201312717318223136879
   PubMed Web of Science ®Google Scholar
• ZipurskyRB.ReillyTJ.MurrayRM.The myth of schizophrenia as a progressive brain disease.Schizophr Bull.2013391363137223172002
   PubMed Web of Science ®Google Scholar
• RobinsonDG.WoernerMG.AlvirJM.et alPredictors of treatment response from a first episode of schizophrenia or schizoaffective disorder.Am J Psychiatry.199915654454910200732
   PubMed Web of Science ®Google Scholar
• CosgroveVE.SuppesT.Informing DSM-5: biological boundaries between bipolar I disorder, schizoaffective disorder, and schizophrenia.BMC Med.20131112723672587
   PubMed Web of Science ®Google Scholar
• JablenskyA.Subtyping schizophrenia: implications for genetic research.Mol Psychiatry.20061181583616801952
   PubMed Web of Science ®Google Scholar
• KaneJM.CorrellCU.Past and present progress in the pharmacologic treatment of schizophrenia. JJ Clin Psychiatry.2010711115112420923620
   PubMed Web of Science ®Google Scholar
• RemingtonG.FoussiasG.AgidO.FervahaG.TakeuchiH.HahnM.The neurobiology of relapse in schizophrenia.Schizophr Res.201415238139024206930
   PubMed Web of Science ®Google Scholar
• OlivaresJM.SermonJ.HemelsM.SchreinerA.Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review.Ann Gen Psychiatry.2013123224148707
   PubMed Web of Science ®Google Scholar
• GaebelW.RiesbeckM.Are there clinically useful predictors and early warning signs for pending relapse?Schizophr Res.201415246947723978776
   PubMed Web of Science ®Google Scholar
• LibermanRP.KopelowiczA.Recovery from schizophrenia: a concept in search of research.Psychiatr Serv.20055673574215939952
   PubMed Web of Science ®Google Scholar
• JääskeläinenE.JuolaP.HirvonenN.et alA systematic review and metaanalysis of recovery in schizophrenia.Schizophr Bull.20133912961230623172003
   PubMed Web of Science ®Google Scholar
• LehmanAF.LiebermanJA.DixonLB.et alAmerican Psychiatric Association; Steering Committee on Practice Guidelines. Practice guideline for the treatment of patients with schizophrenia, second edition.Am J Psychiatry.2004161(2 suppl)15615000267
   PubMedGoogle Scholar
• CorrellCU.KishimotoT.NielsenJ.KaneJ.Clinical relevance of treatments for schizophrenia.Clin Ther.20113361639
   Web of Science ®Google Scholar
• McCabeR.SaidiM.PriebeS.Patient-reported outcomes in schizophrenia.Br J Psychiatry.200750(suppl)s2128
   Google Scholar
• RobinsonD.WoernerMG.AlvirJM.et alPredictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.Arch Gen Psychiatry.19995624124710078501
   PubMed Web of Science ®Google Scholar
• MeltzerHY.Treatment-resistant schizophrenia-the role of clozapine.Curr Med Res Opin.1997141209524789
   PubMed Web of Science ®Google Scholar
• LeuchtS.ArbterD.EngelRR.KisslingW.DavisJM.How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials.Mol Psychiatry.20091442944718180760
   PubMed Web of Science ®Google Scholar
• LambertM.KarowA.LeuchtS.SchimmelmannBG.NaberD.Remission in schizophrenia: validity, frequency, predictors, and patients' perspective 5 years later.Dialogues Clin Neurosci.20101239340720954433
   PubMedGoogle Scholar
• LeuchtS.TardyM.KomossaK.et alAntipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis.Lancet.20123792063207122560607
   PubMed Web of Science ®Google Scholar
• VermaS.SubramaniamM.AbdinE.PoonLY.ChongSA.Symptomatic and functional remission in patients with first-episode psychosis.Acta Psychiatr Scand.201212628228922616617
   PubMed Web of Science ®Google Scholar
• PerkinsD.LiebermanJ.GuH.et alHGDH Research Group. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders.Br J Psychiatry.2004185182415231551
   PubMed Web of Science ®Google Scholar
• PerkinsDO.GuH.WeidenPJ.McEvoyPJ.HamerRM.LiebermanJA.Comparison of Atypicals in First Episode study group. Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study.J Clin Psychiatry.20086910611318312044
   PubMed Web of Science ®Google Scholar
• LevineSZ.RabinowitzJ.EngelR.EtschelE.LeuchtS.Extrapolation between measures of symptom severity and change: an examination of the PANSS and CGI.Schizophr Res.20089831832217949948
   PubMed Web of Science ®Google Scholar
• AndreasenNC.CarpenterWT.JrKaneJM.LasserRA.MarderSR.WeinbergerDR.Remission in schizophrenia: Proposed criteria and rationale for consensus.Am J Psychiatry200516244144915741458
   PubMed Web of Science ®Google Scholar
• GallegoJA.RobinsonDG.SevySM.et alTime to treatment response in first-episode schizophrenia: should acute treatment trials last several months?J Clin Psychiatry.2011721691169621939612
   PubMed Web of Science ®Google Scholar
• BoterH.PeuskensJ.LibigerJ.EUFESTstudy group. Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST).Schizophr Res.20091159710319819114
   PubMed Web of Science ®Google Scholar
• Crespo-FacorroB.de la FozVO.Ayesa-ArriolaR.et alPrediction of acute clinical response following a first episode of non affective psychosis: results of a cohort of 375 patients from the Spanish PAFIP study.Prog Neuropsychopharmacol Biol Psychiatry.20134416216723435091
   PubMed Web of Science ®Google Scholar
• Schennach-WolffR.JagerM.MayrA.et alPredictors of response and remission in the acute treatment of first-episode schizophrenia patients-is it all about early response?Eur Neuropsychopharmacol.20112137037821255982
   PubMed Web of Science ®Google Scholar
• NordonC.RouillonF.AzorinJM.BarryC.UrbachM.FalissardB.Trajectories of antipsychotic response in drug-naive schizophrenia patients: results from the 6-month ESPASS follow-up study.Acta Psychiatr Scand.201412911612523600715
   PubMed Web of Science ®Google Scholar
• ZhangHX.ShenXL.ZhouH.YangXM.WangHF.JiangKD.Predictors of response to second generation antipsychotics in drug naive patients with schizophrenia: a 1 year follow-up study in Shanghai.Psychiatry Res.2014215202524230993
   PubMed Web of Science ®Google Scholar
• AddingtonJ.AddingtonD.Symptom remission in first episode patients.Schizophr Res.200810628128518926666
   PubMed Web of Science ®Google Scholar
• EmsleyR.OosthuizenPP.KiddM.KoenL.NiehausDJ.TurnerHJ.Remission in first-episode psychosis: predictor variables and symptom improvement patterns.J Clin Psychiatry.2006671707171217196049
   PubMed Web of Science ®Google Scholar
• EmsleyR.RabinowitzJ.MedoriR.Early Psychosis Global Working Group. Remission in early psychosis: rates, predictors, and clinical and functional outcome correlates.Schizophr Res.20078912913917095194
   PubMed Web of Science ®Google Scholar
• AgidO.ArenovichT.SajeevG.et alAn algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis.J Clin Psychiatry.2011721439144421457676
   PubMed Web of Science ®Google Scholar
• AlbertN.BertelsenM.ThorupA.et alPredictors of recovery from psychosis Analyses of clinical and social factors associated with recovery among patients with first-episode psychosis after 5 years.Schizophr Res.201112525726621056926
   PubMed Web of Science ®Google Scholar
• ChangWC.HuiCL.TangJY.WongGH.LamMM.ChanSK.ChenEY.Persistent negative symptoms in first-episode schizophrenia: a prospective three-year follow-up study.Schizophr Res.2011133222821968080
   PubMed Web of Science ®Google Scholar
• ChangWC.TangJY.HuiCL.et alDuration of untreated psychosis: relationship with baseline characteristics and three-year outcome in firstepisode psychosis.Psychiatry Res.201219836036522425475
   PubMed Web of Science ®Google Scholar
• Crespo-FacorroB.Pelayo-TeranJM.Perez-lglesiasR.et alPredictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables.J Psychiatr Res.20074165966616797591
   PubMed Web of Science ®Google Scholar
• DerksEM.FleischhackerWW.BoterH.PeuskensJ.KahnRS.EUFEST Study Group. Antipsychotic drug treatment in first-episode psychosis: should patients be switched to a different antipsychotic drug after 2, 4, or 6 weeks of nonresponse?J Clin Psychopharmacol.20103017618020520291
   PubMed Web of Science ®Google Scholar
• DiazI.Pelayo-TeranJM.Perez-lglesiasR.et alPredictors of clinical remission following a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables.Psychiatry Res.201320618118723159063
   PubMed Web of Science ®Google Scholar
• GaebelW.RiesbeckM.WolwerW.et alRates and predictors of remission in first-episode schizophrenia within 1 year of antipsychotic maintenance treatment. Results of a randomized controlled trial within the German Research Network on Schizophrenia.Schizophr Res.201415247848623643327
   PubMed Web of Science ®Google Scholar
• JohnsonS.SathyaseelanM.CharlesH.JeyaseelanV.JacobKS.Insight, psychopathology, explanatory models and outcome of schizophrenia in India: a prospective 5-year cohort study.BMC Psychiatry.20121215923013057
   PubMed Web of Science ®Google Scholar
• LambertM.NaberD.SchachtA.WagnerT.HundemerHP.KarowA.HuberCG.SuarezD.HaroJM.NovickD.DittmannRW.SchimmelmannBG.Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia.Acta Psychiatr Scand.200811822022918699954
   PubMed Web of Science ®Google Scholar
• LevineSZ.RabinowitzJ.Trajectories and antecedents of treatment response over time in early-episode psychosis.Schizophr Bull.20103662463218849294
   PubMed Web of Science ®Google Scholar
• LevineSZ.RabinowitzJ.CaseM.Ascher-SvanumH.Treatment response trajectories and their antecedents in recent-onset psychosis: a 2-year prospective study.J Clin Psychopharmacol.203044644920631562
   PubMed Web of Science ®Google Scholar
• MallaA.NormanR.SchmitzN.et alPredictors of rate and time to remission in first-episode psychosis: a two-year outcome study.Psychol Med.20063664965816515734
   PubMed Web of Science ®Google Scholar
• Pelayo-TeranJM.DiazFJ.Perez-lglesiasR.et alTrajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis.Psychol Med.201444375023461899
   PubMed Web of Science ®Google Scholar
• PetersenL.ThorupA.0qhlenschlaegerJ.et alPredictors of remission and recovery in a first-episode schizophrenia spectrum disorder sample: 2-year follow-up of the OPUS trial.Can J Psychiatry.20085366067018940034
   PubMed Web of Science ®Google Scholar
• SaravananB.JacobKS.JohnsonS.PrinceM.BhugraD.DavidAS.Outcome of first-episode schizophrenia in India: longitudinal study of effect of insight and psychopathology.Br J Psychiatry.201019645445920513855
   PubMed Web of Science ®Google Scholar
• SeltenJP.VeenND.HoekHW.et alEarly course of schizophrenia in a representative Dutch incidence cohort.Schizophr Res.200797798717683911
   PubMed Web of Science ®Google Scholar
• SimonsenE.FriisS.OpjordsmoenS.et alEarly identification of nonremission in first-episode psychosis in a two-year outcome study.Acta Psychiatr Scand.201012237538320722632
   PubMed Web of Science ®Google Scholar
• StaufferVL.CaseM.KinonBJ.et alEarly response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis.Psychiatry Res.2011187424821168920
   PubMed Web of Science ®Google Scholar
• Stentebjerg-OlesenM.JeppesenP.PagsbergAK.et alEarly nonresponse determined by the clinical global impressions scale predicts poorer outcomes in youth with schizophrenia spectrum disorders naturalistically treated with second-generation antipsychotics.J Child Adolesc Psychopharmacol.20132366567524266529
   PubMed Web of Science ®Google Scholar
• UcokA.SerbestS.KandemirPE.Remission after first-episode schizophrenia: results of a long-term follow-up.Psychiatry Res.2011189333721196051
   PubMed Web of Science ®Google Scholar
• VenturaJ.SubotnikKL.GuzikLH.et alRemission and recovery during the first outpatient year of the early course of schizophrenia.Schizophr Res.2011132182321764563
   PubMed Web of Science ®Google Scholar
• WunderinkL.SytemaS.NienhuisFJ.WiersmaD.Clinical recovery in first-episode psychosis.Schizophr Bull.20093536236918990715
   PubMed Web of Science ®Google Scholar
• GalderisiS.BucciP.UcokA.PeuskensJ.No gender differences in social outcome in patients suffering from schizophrenia.Eur Psychiatry.20122740640821616645
   PubMed Web of Science ®Google Scholar
• WunderinkL.NieboerRM.WiersmaD.SytemaS.NienhuisFJ.Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial.JAMA Psychiatry.20137091392023824214
   PubMed Web of Science ®Google Scholar
• ClemmensenL.VernalDL.SteinhausenHC.A systematic review of the long-term outcome of early onset schizophrenia.BMC Psychiatry.20121215022992395
   PubMed Web of Science ®Google Scholar
• NielsenJ.NielsenRE.CorrellCU.Predictors of clozapine response in patients with treatment-refractory schizophrenia: results from a Danish Register Study.J Clin Psychopharmacol.20123267868322926603
   PubMed Web of Science ®Google Scholar
• TeferraS.ShibreT.FekaduA.et alFive-year clinical course and outcome of schizophrenia in Ethiopia.Schizophr Res.201213613714222104140
   PubMed Web of Science ®Google Scholar
• SemizUB.CetinM.BasogluC.et alClinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.Prog Neuropsychopharmacol Biol Psychiatry.2007311330133617618026
   PubMed Web of Science ®Google Scholar
• JeppesenP.PetersenL.ThorupA.et alThe association between premorbid adjustment, duration of untreated psychosis and outcome in firstepisode psychosis.Psychol Med.2008381157116618447961
   PubMed Web of Science ®Google Scholar
• KuriharaT.KatoM.RevergerR.TirtaIG.Remission in schizophrenia: a community-based 6-year follow-up study in Bali.Psychiatry Clin Neurosci.20116547648221851456
   PubMed Web of Science ®Google Scholar
• ThirthalliJ.ChannaveerachariNK.SubbakrishnaDK.CottierLB.VargheseM.GangadharBN.Prospective study of duration of untreated psychosis and outcome of never-treated patients with schizophrenia in India.Indian J Psychiatry.20115331932322303040
   PubMedGoogle Scholar
• RabinowitzJ.WerbeloffN.CaersI.et alDeterminants of antipsychotic response in schizophrenia: implications for practice and future clinical trials.J Clin Psychiatry.201475e308e31624813414
   PubMed Web of Science ®Google Scholar
• LevineSZ.LeuchtS.Treatment response heterogeneity in the predominant negative symptoms of schizophrenia: analysis of amisulpride vs placebo in three clinical trials.Schizophr Res.201415610711424794879
   PubMed Web of Science ®Google Scholar
• LarsenTK.MoeLC.Vibe-HansenL.JohannessenJO.Premorbid functioning versus duration of untreated psychosis in 1 year outcome in firstepisode psychosis.Schizophr Res.2000451910978867
   PubMed Web of Science ®Google Scholar
• BottlenderR.SatoT.JagerM.et alThe impact of the duration of untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia.Schizophr Res.200362374412765741
   PubMed Web of Science ®Google Scholar
• JonsdottirH.OpjordsmoenS.BirkenaesAB.et alPredictors of medication adherence in patients with schizophrenia and bipolar disorder.Acta Psychiatr Scand.2013127233322900964
   PubMed Web of Science ®Google Scholar
• ThorupA.AlbertN.BertelsenM.et alGender differences in first-episode psychosis at 5-year follow-up-two different courses of disease? Results from the OPUS study at 5-year follow-up.Eur Psychiatry.201429445123394824
   PubMed Web of Science ®Google Scholar
• JinJ.SklarGE.OhVMS.LiS.Factors affecting therapeutic compliance: a review from the patient's perspective.Ther Clin Risk Manag.2008426928618728716
   PubMedGoogle Scholar
• SpellmannI.RiedelM.SchennachR.et alOne-year functional outcomes of naturalistically treated patients with schizophrenia.Psychiatry Res.201219837838522421065
   PubMed Web of Science ®Google Scholar
• RabinowitzJ.HarveyPD.EerdekensM.DavidsonM.Premorbid functioning and treatment response in recent-onset schizophrenia.Br J Psychiatry.2006189313516816303
   PubMed Web of Science ®Google Scholar
• WilderJ.The law of initial value in neurology and psychiatry: Facts and problems.J Nerv Ment Dis.1957125738613481701
   PubMed Web of Science ®Google Scholar
• LambertM.SchimmelmannBG.NaberD.et alPrediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia.J Clin Psychiatry.2006671690169717196047
   PubMed Web of Science ®Google Scholar
• FentonWS.McGlashanTH.Natural history of schizophrenia subtypes. II. Positive and negative symptoms and long-term course.Arch Gen Psychiatry.1991489789861747021
   PubMed Web of Science ®Google Scholar
• FentonWS.McGlashanTH.Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia.Am J Psychiatry.19941513513567906493
   PubMed Web of Science ®Google Scholar
• FoussiasG.RemingtonG.Negative symptoms in schizophrenia: avolition and Occam's razor.Schizophr Bull.20103635936918644851
   PubMed Web of Science ®Google Scholar
• FervahaG.FoussiasG.AgidO.RemingtonG.Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia.Acta Psychiatr Scand.201413029029924850369
   PubMed Web of Science ®Google Scholar
• BowieCR.LeungWW.ReichenbergA.et alPredicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures.Biol Psychiatry.20086350551117662256
   PubMed Web of Science ®Google Scholar
• RabinowitzJ.LevineSZ.GaribaldiG.Bugarski-KirolaD.BerardoCG.KapurS.Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data.Schizophr Res.201213714715022316568
   PubMed Web of Science ®Google Scholar
• SchimmelmannBG.ConusP.CottonS.McGorryPD.LambertM.Pretreatment, baseline, and outcome differences between early-onset and adult-onset psychosis in an epidemiological cohort of 636 first-episode patients.Schizophr Res.2007951817628441
   PubMed Web of Science ®Google Scholar
• AmmingerGP.HenryLP.HarriganSM.et alOutcome in early-onset schizophrenia revisited: findings from the Early Psychosis Prevention and Intervention Centre long-term follow-up study.Schizophr Res.201113111211921741219
   PubMed Web of Science ®Google Scholar
• EmsleyR.OosthuizenPP.KoenL.NiehausDJ.MartinezG.Symptom recurrence following intermittent treatment in first-episode schizophrenia successfully treated for 2 years: a 3-year open-label clinical study.J Clin Psychiatry.201273e541e54722579160
   PubMedGoogle Scholar
• EmsleyR.NuamahI.HoughD.GopalS.Treatment response after relapse in a placebo-controlled maintenance trial in schizophrenia.Schizophr Res.2012138293422446143
   PubMed Web of Science ®Google Scholar
• KeefeRS.BilderRM.HarveyPD.et alBaseline neurocognitive deficits in the CATIE schizophrenia trial.Neuropsychopharmacology2006312033204616641947
   PubMed Web of Science ®Google Scholar
• GalderisiS.DavidsonM.KahnRS.et alEUFEST group. Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study.Schizophr Res.200911510411419822407
   PubMed Web of Science ®Google Scholar
• GoldS.ArndtS.NopoulosP.O'LearyDS.AndreasenNC.Longitudinal Study of cognitive function in first-episode and recent-onset schizophrenia.Am J Psychiatry19991561342134810484943
   PubMed Web of Science ®Google Scholar
• StirlingJ.WhiteC.LewisS.et alNeurocognitive function and outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort.Schizophr Res.200365758614630300
   PubMed Web of Science ®Google Scholar
• MilevP.HoBC.ArndtS.AndreasenNC.Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up.Am J Psychiatry.200516249550615741466
   PubMed Web of Science ®Google Scholar
• Tabares-SeisdedosR.Balanza-MartinezV.Sanchez-MorenoJ.et alNeurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.J Affect Disord.200810928629918289698
   PubMed Web of Science ®Google Scholar
• KurtzMM.Neurocognition as a predictor of response to evidencebased psychosocial interventions in schizophrenia: what is the state of the evidence?Clin Psychol Rev.20113166367221482324
   PubMed Web of Science ®Google Scholar
• JordanG.LutgensD.JooberR.LepageM.IyerS.MallaA.The relative contribution of cognition and symptomatic remission to functional outcome following treatment of a first episode of psychosis.J Clin Psychiatry201475e566e57225004197
   PubMed Web of Science ®Google Scholar
• AllottK. Liu P, Proffitt TM, Killackey E. Cognition at illness onset as a predictor of later functional outcome in early psychosis: systematic review and methodological critique.Schizophr Res.201112522123521111577
   PubMed Web of Science ®Google Scholar
• BilderRM.GoldmanRS.VolavkaJ.et alNeurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.Am J Psychiatry.20021591018102812042192
   PubMed Web of Science ®Google Scholar
• ZipurskyRB.Why are the outcomes in patients with schizophrenia so poor?J Clin Psychiatry.201475(suppl 2)202424919167
   PubMed Web of Science ®Google Scholar
• ThomaP.DaumI.Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings.Psychiatry Clin Neurosci.20136736738323890122
   PubMed Web of Science ®Google Scholar
• ConleyRR.Ascher-SvanumH.ZhuB.FariesDE.KinonBJ.The burden of depressive symptoms in the long-term treatment of patients with schizophrenia.Schizophr Res.20079018619717110087
   PubMed Web of Science ®Google Scholar
• EatonWW.TharaR.FedermanE.TienA.Remission and relapse in schizophrenia: the Madras Longitudinal Study.J Nerv Ment Dis.19981863573639653420
   PubMed Web of Science ®Google Scholar
• OosthuizenP.EmsleyRA.RobertsMC.et alDepressive symptoms at baseline predict fewer negative symptoms at follow-up in patients with first-episode schizophrenia.Schizophr Res.20025824725212409165
   PubMed Web of Science ®Google Scholar
• HaroJM.NovickD.BertschJ.KaragianisJ.DossenbachM.JonesPB.Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) study.Br J Psychiatry.201119919420121881098
   PubMed Web of Science ®Google Scholar
• CaseiroO.Perez-lglesiasR.MataI.et alPredicting relapse after a first episode of non-affective psychosis: a three-year follow-up study.J Psychiatr Res.2012461099110522721546
   PubMed Web of Science ®Google Scholar
• EmsleyR.ChilizaB.AsmalL.The evidence for illness progression after relapse in schizophrenia.Schizophr Res.201314811712123756298
   PubMed Web of Science ®Google Scholar
• MenezesNM.ArenovichT.ZipurskyRB.A systematic review of longitudinal outcome studies of first-episode psychosis.Psychol Med.2006361349136216756689
   PubMed Web of Science ®Google Scholar
• HuhnM.TardyM.SpineliLM.et alEfficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses.JAMA. Psychiatry.20147170671524789675
   PubMed Web of Science ®Google Scholar
• CorrellCU.MalhotraAK.KaushikS.McMenimanM.KaneJM.Early prediction of antipsychotic response in schizophrenia.Am J Psychiatry.20031602063206514594760
   PubMed Web of Science ®Google Scholar
• LeuchtS.ShamsiSA.BuschR.KisslingW.KaneJM.Predicting antipsychotic drug response - replication and extension to six weeks in an international olanzapine study.Schizophr Res.200810131231918308513
   PubMed Web of Science ®Google Scholar
• Ascher-SvanumH.NyhuisAW.FariesDE.KinonBJ.BakerRW.ShekharA.Clinical, functional, and economic ramifications of early nonresponse to antipsychotics in the naturalistic treatment of schizophrenia.Schizophr Bull.2008341163117118156640
   PubMed Web of Science ®Google Scholar
• KinonBJ.ChenL.Ascher-SvanumH.et alPredicting response to atypical antipsychotics based on early response in the treatment of schizophrenia.Schizophr Res.200810223024018423985
   PubMed Web of Science ®Google Scholar
• JagerM.SchmaussM.LauxG.et alEarly improvement as a predictor of remission and response in schizophrenia: results from a naturalistic study.Eur Psychiatry.20092450150619559572
   PubMed Web of Science ®Google Scholar
• KinonBJ.ChenL.Ascher-SvanumH.et alEarly response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia.Neuropsychopharmacology.20103558159019890258
   PubMed Web of Science ®Google Scholar
• HattaK.OtachiT.SudoY.et alJAST Study Group. Difference in early prediction of antipsychotic non-response between risperidone and olanzapine in the treatment of acute-phase schizophrenia.Schizophr Res.201112812713521420283
   PubMed Web of Science ®Google Scholar
• SchennachR.RiesbeckM.MayrA.et alShould early improvement be re-defined to better predict the maintenance of response in first-episode schizophrenia patients?Acta Psychiatr Scand.201312747448122957829
   PubMed Web of Science ®Google Scholar
• van denOord EJ.AdkinsDE.McClayJ.LiebermanJ.SullivanPF.A systematic method for estimating individual responses to treatment with antipsychotics in CATIE.Schizophr Res.2009107132118930379
   PubMed Web of Science ®Google Scholar
• RubergSJ.ChenL.StaufferV.et alIdentification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia.BMC Psychiatry.2011112321306626
   PubMed Web of Science ®Google Scholar
• ButzlaffRL.HooleyJM.Expressed emotion and psychiatric relapse: a meta-analysis.Arch Gen Psychiatry.199855547529633674
   PubMed Web of Science ®Google Scholar
• KoutraK.VgontzasAN.LionisC.TrilivaS.Family functioning in firstepisode psychosis: a systematic review of the literature.Soc Psychiatry Psychiatr Epidemiol.2014491023103624407976
   PubMed Web of Science ®Google Scholar
• PerkinsDO.GuH.BotevaK.LiebermanJA.Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis.Am J Psychiatry.20051621785180416199825
   PubMed Web of Science ®Google Scholar
• MarshallM.LewisS.LockwoodA.DrakeR.JonesP.CroudaceT.Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review.Arch Gen Psychiatry.20056297598316143729
   PubMed Web of Science ®Google Scholar
• LoebelAD.LiebermanJA.AlvirJM.MayerhoffDl.GeislerSH.SzymanskiSR.Duration of psychosis and outcome in first-episode schizophrenia.Am J Psychiatry.1992149118311881503130
   PubMed Web of Science ®Google Scholar
• DrakeRJ.HaleyCJ.AkhtarS.LewisSW.Causes and consequences of duration of untreated psychosis in schizophrenia.Br J Psychiatry.200017751151511102325
   PubMed Web of Science ®Google Scholar
• UcokA.PolatA.GeneA.CakirS.TuranN.Duration of untreated psychosis may predict acute treatment response in first-episode schizophrenia.J Psychiatr Res.20043816316814757330
   PubMed Web of Science ®Google Scholar
• UcokA.PolatA.CakirS.GeneA.One year outcome in first episode schizophrenia. Predictors of relapse.Eur Arch Psychiatry Clin Neurosci.2006256374316010602
   PubMed Web of Science ®Google Scholar
• CechnickiA.CichockiL.KaliszA.BtadzinskiP.AdamczykP.FranczykGlita J.Duration of untreated psychosis (DUP) and the course of schizophrenia in a 20-year follow-up study.Psych Res.2014219420425
   PubMed Web of Science ®Google Scholar
• CechnickiA.HanuszkiewiczI.PolczykR.BielafiskaA.Prognostic value of duration of untreated psychosis in long-term outcome of schizophrenia.MedSciMonit.201117CR277CR283
   Google Scholar
• HarrisMG.HenryLP.HarriganSM.et alThe relationship between duration of untreated psychosis and outcome: an eight-year prospective study.Schizophr Res.200579859316005612
   PubMed Web of Science ®Google Scholar
• WhiteC.StirlingJ.HopkinsR.et alPredictors of 10-year outcome of first-episode psychosis.Psychol Med.2009391447145619187566
   PubMed Web of Science ®Google Scholar
• Alvarez-JimenezM.GleesonJF.HenryLP.et alPrediction of a single psychotic episode: a 7.5-year, prospective study in first-episode psychosis.Schizophr Res.201112523624621081266
   PubMed Web of Science ®Google Scholar
• TirupatiNS.RangaswamyT.RamanP.Duration of untreated psychosis and treatment outcome in schizophrenia patients untreated for many years.Aust N Z J Psychiatry.20043833934315144511
   PubMed Web of Science ®Google Scholar
• GerlingerG.HauserM.De HertM.et alPersonal stigma in schizophrenia-spectrum disorders: a systematic review of prevalence rates, correlates, impact and interventions.World Psychiatry ;201312155164
   PubMed Web of Science ®Google Scholar
• AgidO.KapurS.ArenovichT.ZipurskyRB.Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected.Arch Gen Psychiatry.2003601228123514662555
   PubMed Web of Science ®Google Scholar
• LeuchtS.BuschR.HamannJ.KisslingW.KaneJM.Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended.Biol Psychiatry.2005571543154915953491
   PubMed Web of Science ®Google Scholar
• EmsleyR.RabinowitzJ.MedoriR.Time course for antipsychotic treatment response in first-episode schizophrenia.Am J Psychiatry.200616374374516585455
   PubMed Web of Science ®Google Scholar
• JagerM.RiedelM.MesserT.et alPsychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders.Eur Arch Psychiatry Clin Neurosci.2007257475317033915
   PubMed Web of Science ®Google Scholar
• JagerM.RiedelM.ObermeierM.et alTime course of antipsychotic treatment response in schizophrenia: results from a naturalistic study in 280 patients.Schizophr Res.201011818318820181461
   PubMed Web of Science ®Google Scholar
• ZhangJP.GallegoJ.RobinsonD.MalhotraAK.KaneJM.CorrellCU.Efficacy and safety of individual second-generation vs first-generation antipsychotics in first episode schizophrenia: a systematic review and metaanalysis.Int J Neuropsychopharm.20131612051218
   PubMed Web of Science ®Google Scholar
• CorrellCU.LenczT.MalhotraAK.Antipsychotic drugs and obesity.Trends Mol Med.2011179710721185230
   PubMed Web of Science ®Google Scholar
• KinonBJ.Ascher-SvanumH.AdamsDH.ChenL.The temporal relationship between symptom change and treatment discontinuation in a pooled analysis of 4 schizophrenia trials.J Clin Psychopharmacol.20082854454918794651
   PubMed Web of Science ®Google Scholar
• FariesD.Ascher-SvanumH.PhillipsG.et alConstruct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients' and clinicians' perspectives in a clinical trial.BMC Med Res Methodol.20121214222974273
   PubMed Web of Science ®Google Scholar
• WunderinkL.NienhuisFJ.SytemaS.SlooffCJ.KnegteringR.WiersmaD.Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome.J Clin Psychiatry.20076865466117503973
   PubMed Web of Science ®Google Scholar
• WiersmaD.NienhuisFJ.SlooffCJ.GielR.Natural course of schizophrenic disorders: a 15-year follow-up of a Dutch incidence cohort.Schizophr Bull.19982475859502547
   PubMed Web of Science ®Google Scholar
• DemjahaA.EgertonA.MurrayRM.et alAntipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function.Biol Psychiatry.201475e11323890739
   PubMed Web of Science ®Google Scholar
• ClarkSL.AdkinsDE.van denOord EJ.Analysis of efficacy and side effects in CATIE demonstrates drug response subgroups and potential for personalized medicine.Schizophr Res.201113211412021872442
   PubMed Web of Science ®Google Scholar
• LiebermanJA.StroupTS.McEvoyJP.et alClinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.N Engl J Med.20053531209122316172203
   PubMed Web of Science ®Google Scholar
• LiebermanJA.KoreenAR.ChakosM.et alFactors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophrenia.J Clin Psychiatry.199657(suppl9)598823344
   PubMed Web of Science ®Google Scholar
• CassidyCM.NormanR.ManchandaR.SchmitzN.MallaA.Testing definitions of symptom remission in first-episode psychosis for prediction of functional outcome at 2 years.Schizophr Bull.2010361001100819321629
   PubMed Web of Science ®Google Scholar
• BodenR.SundstromJ.LindstromE.LindstromL.Association between symptomatic remission and functional outcome in first-episode schizophrenia.Schizophr Res.200910723223718957275
   PubMed Web of Science ®Google Scholar
• BilderRM.GoldmanRS.RobinsonD.et alNeuropsychology of firstepisode schizophrenia: initial characterization and clinical correlates.Am J Psychiatry.200015754955910739413
   PubMed Web of Science ®Google Scholar
• HoBC.AndreasenNC.ZiebellS.PiersonR.MagnottaV.Long-term antipsychotic treatment and brain volumes: a longitudinal study of firstepisode schizophrenia.Arch Gen Psychiatry.20116812813721300943
   PubMed Web of Science ®Google Scholar
• KaneJM.KishimotoT.CorrellCU.Factors contributing to non-adherence in patients with psychotic disorders.World Psychiatry.20131221622624096780
   PubMed Web of Science ®Google Scholar
• AndreasenNC.LiuD.ZiebellS.VoraA.HoBC.Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study.Am J Psychiatry.201317060961523558429
   PubMed Web of Science ®Google Scholar
• EmsleyR.ChilizaB.AsmalL.et alA randomized, controlled trial of omega-3 fatty acids plus an antioxidant for relapse prevention after antipsychotic discontinuation in first-episode schizophrenia.Schizophr Res.201415823023524996507
   PubMed Web of Science ®Google Scholar